The Dawn of New Medicine
Stem Cell Therapy: Old Dogma, New Hope
Seiten
2024
Matador (Verlag)
978-1-80313-208-2 (ISBN)
Matador (Verlag)
978-1-80313-208-2 (ISBN)
Stem cell therapy, otherwise known as the regenerative medicine, promotes the regrow, repair or replacement of the diseased, dysfunctional or damaged tissues using stem cells. The Dawn of New Medicine expresses stem cells therapy as the new hope in modern medicine. This book explores the holistic dimension of stem cells therapy, from the basics of stem cell therapy to the possibilities it may bring to modern medicine.
Chronic diseases have stolen joy from a lot of people when, as a patient ourselves or when someone close to us was diagnosed with an illness for which there was no solution to. While symptoms of these diseases are often managed by medication and medicinal services, stem cells therapy go beyond the conventional management to discover therapies that support to body to repair, regenerate and restore. This book wishes to enlighten readers that there might be hope in managing diseases such as Down Syndrome, Autism Spectrum, Cerebral Palsy and global developmental delay as mentioned in this book.
Professor Dato’ Sri Dr. Mike KS Chan is a scientist, senior researcher, educator and expert in anti-aging owning 26 medical wellness centers including hospitals Germany), clinics (Lugano, Switzerland), medical centers (Athens, Greece), and wellness clinics (Switzerland, Bangkok, Hong Kong, China, Malaysia-Kuala Lumpur, and Kota Kinabalu, Manila, Mexico, Ecuador, Frankfurt, Germany, Switzerland, Cambodia, Bangladesh, etc.). His precious experience and findings he gathered in his 36 years of advancing this field, he shares it here.
Chronic diseases have stolen joy from a lot of people when, as a patient ourselves or when someone close to us was diagnosed with an illness for which there was no solution to. While symptoms of these diseases are often managed by medication and medicinal services, stem cells therapy go beyond the conventional management to discover therapies that support to body to repair, regenerate and restore. This book wishes to enlighten readers that there might be hope in managing diseases such as Down Syndrome, Autism Spectrum, Cerebral Palsy and global developmental delay as mentioned in this book.
Professor Dato’ Sri Dr. Mike KS Chan is a scientist, senior researcher, educator and expert in anti-aging owning 26 medical wellness centers including hospitals Germany), clinics (Lugano, Switzerland), medical centers (Athens, Greece), and wellness clinics (Switzerland, Bangkok, Hong Kong, China, Malaysia-Kuala Lumpur, and Kota Kinabalu, Manila, Mexico, Ecuador, Frankfurt, Germany, Switzerland, Cambodia, Bangladesh, etc.). His precious experience and findings he gathered in his 36 years of advancing this field, he shares it here.
Prof. Dr. Mike K.S. Chan is a Senior Researcher, Educator and author of multiple books on Biological, Integrative and Regenerative Medicine, including stem cells, with over three decades of experience in all of the fields. He is an Associate Professor of American Academy of Stem Cell Physicians (AASCP) and Board Member/Head of Regenerative Medicine of several world-renowned organisations including European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM).
Erscheinungsdatum | 30.01.2024 |
---|---|
Verlagsort | Market Harborough |
Sprache | englisch |
Maße | 203 x 254 mm |
Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
ISBN-10 | 1-80313-208-6 / 1803132086 |
ISBN-13 | 978-1-80313-208-2 / 9781803132082 |
Zustand | Neuware |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Die revolutionäre Medizin von morgen (Lifespan)
Buch | Softcover (2020)
DuMont Buchverlag
CHF 22,40
Eine sehr persönliche Geschichte | Der New York Times-Bestseller
Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
CHF 30,75
Buch | Softcover (2022)
John Wiley & Sons Inc (Verlag)
CHF 169,95